CMX157 Antiviral HIV Medication Trials
Links shared publicly online about this topic
Chimerix's Antiviral CMX157 Demonstrates Positive Phase 1 Clinical Results With Favorable Pharmacokinetics, Safety And Tolerability
medicalnewstoday.com — “Chimerix, Inc., a pharmaceutical company developing orally-available antiviral therapeutics, today announced first-in-human Phase 1 clinical trial results for CMX157 demonstrating a favorable safe” View full resource at medicalnewstoday.com
Most Recently Shared on December 15, 2010 at 6:05 pm By:
Chimerix's Antiviral CMX157 Demonstrates Positive Phase 1 Clinical Results With Favorable Pharmacokinetics, Safety And... http://mnt.to/3P6q
Chimerix's Antiviral CMX157 Demonstrates Positive Phase 1 Clinical Results With Favorable Pharmacokinetics, Safety and Tolerability - Drugs.com MedNews
drugs.com — “Exhibits Potent In Vitro Activity Against XMRV and Highly Resistant HIV DURHAM, N.C., Chimerix, Inc., a pharmaceutical company developing orally-available antiv” View full resource at drugs.com
Most Recently Shared on December 13, 2010 at 3:07 pm By:
Drugs and Devices OW OW Health
Chimerix's Antiviral CMX157 Demonstrates Positive Phase 1 Clinical Results With Favorable Pharmacokinetics... http://bit.ly/fuEvfP #drug
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
MNT HIV/Aids
The latest HIV/Aids news published daily. Articles from research centers, universities and prestigious journals.
-
Drugs and Devices OW
Organizing drug and medical device resources shared by health experts, advocates, and organizations into WisdomCards.
Advertisement
